The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?
暂无分享,去创建一个
M. Khoury | M. Gwinn | N. Dowling | C. Moore | L. Bradley | P. Yoon | C. Moore | M. Khoury | Nicole F. Dowling
[1] R. Hoover. The evolution of epidemiologic research: from cottage industry to "big" science. , 2007, Epidemiology.
[2] K. Christensen,et al. What genome-wide association studies can do for medicine. , 2007, The New England journal of medicine.
[3] Muin J. Khoury,et al. The path from genome-based research to population health: Development of an international public health genomics network , 2006, Genetics in Medicine.
[4] E. Beutler,et al. Hereditary hemochromatosis: screening and management. , 2006, Current hematology reports.
[5] S Kamen,et al. The task force. , 1976, Journal of hospital dental practice.
[6] H. Nelson,et al. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement , 2005 .
[7] C. Lenfant. Shattuck lecture--clinical research to clinical practice--lost in translation? , 2003, The New England journal of medicine.
[8] Colleen M McBride. Blazing a Trail: A Public Health Research Agenda in Genomics and Chronic Disease , 2005, Preventing chronic disease.
[9] L. Grummer-Strawn,et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. , 2001, JAMA.
[10] Gary H Lyman,et al. Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis. , 2006, Clinical breast cancer.
[11] K. Sonntag,et al. The antitumor immune response in HER-2 positive, metastatic breast cancer patients , 2005, Journal of Translational Medicine.
[12] Alastair Baker,et al. Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.
[13] Muin J Khoury,et al. Research priorities for evaluating family history in the prevention of common chronic diseases. , 2003, American journal of preventive medicine.
[14] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[15] J. R. Scotti,et al. Available From , 1973 .
[16] C Sue Richards,et al. Alternative approaches to proficiency testing in molecular genetics. , 2003, Clinical Chemistry.
[17] D. Mrazek,et al. The impact of CYP allelic variation on antidepressant metabolism: a review , 2007, Expert opinion on drug metabolism & toxicology.
[18] M. Khoury,et al. Genomic profiling to promote a healthy lifestyle: not ready for prime time , 2003, Nature Genetics.
[19] F. Marincola,et al. Obstacles and opportunities in translational research , 2005, Nature Medicine.
[20] M. Olivier. A haplotype map of the human genome. , 2003, Nature.
[21] Roberta A Pagon,et al. GeneTests: an online genetic information resource for health care providers. , 2006, Journal of the Medical Library Association : JMLA.
[22] M. Piccart,et al. Achievements in systemic therapies in the pregenomic era in metastatic breast cancer. , 2007, The oncologist.
[23] H. Pass,et al. Translation research: from accurate diagnosis to appropriate treatment , 2004, Journal of Translational Medicine.
[24] Susan E. Kutner. Breast cancer genetics and managed care , 2022 .
[25] Elizabeth Lobb,et al. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk , 2007, Breast Cancer Research and Treatment.
[26] Michael J Green,et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. , 2004, JAMA.
[27] F. Collins,et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. , 1998, JAMA.
[28] Kenneth Wells,et al. Strategies for academic and clinician engagement in community-participatory partnered research. , 2007, JAMA.
[29] Inder M. Verma,et al. The NIH Roadmap , 2004 .
[30] J. Kirk,et al. A Randomized Controlled Trial of a Decision Aid for Women at Increased Risk of Ovarian Cancer , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[31] Francis S Collins,et al. Realizing the promise of genomics in biomedical research. , 2005, JAMA.
[32] E. Zerhouni,et al. The Biomarkers Consortium: public and private sectors working in partnership to improve the public health. , 2007, The Oncologist.
[33] M. Khoury,et al. Contribution of different HFE genotypes to iron overload disease: a pooled analysis , 2000, Genetics in Medicine.
[34] Lori Armstrong,et al. Genetic testing for susceptibility to breast and ovarian cancer: Evaluating the impact of a direct-to-consumer marketing campaign on physicians' knowledge and practices , 2006, Genetics in Medicine.
[35] F. Collins,et al. The family history--more important than ever. , 2004, The New England journal of medicine.
[36] E. Lander,et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.
[37] L W Green,et al. A dissemination research agenda to strengthen health promotion and disease prevention. , 1996, Canadian journal of public health = Revue canadienne de sante publique.
[38] D. Mendrick. Current trends and strategic directions in the use of pharmacogenomics to identify translational biomarkers. , 2007, Current opinion in drug discovery & development.
[39] M. Khoury,et al. The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: An update , 2006, Genetics in Medicine.
[40] J. Koziol,et al. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA , 2002, The Lancet.
[41] R. Leone,et al. Niflumic Acid and Mucocutaneous Reactions , 2006, Pediatrics.
[42] J. Sallis,et al. Health promotion research and the diffusion and institutionalization of interventions. , 1999, Health education research.
[43] John P. A. Ioannidis,et al. The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities , 2007, Epidemiology.
[44] E. Zerhouni. Translational and clinical science--time for a new vision. , 2005, The New England journal of medicine.
[45] R. G. Parrish,et al. Hemochromatosis-Associated Mortality in the United States from 1979 to 1992: An Analysis of Multiple-Cause Mortality Data , 1998, Annals of Internal Medicine.
[46] K. Emmons,et al. Introduction to the special section on dissemination: dissemination research and research dissemination: how can we close the gap? , 2005, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[47] E. Zerhouni. The NIH Roadmap , 2003, Science.
[48] Pamela W Duncan,et al. Sex Differences in Stroke Recovery , 2005, Preventing chronic disease.
[49] P. Arn,et al. Newborn screening: current status. , 2007, Health affairs.
[50] O. Boussif,et al. Enhanced in vitro and in vivo cationic lipid‐mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid , 2001, The journal of gene medicine.
[51] J. Benkendorf,et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. , 1997, Journal of the National Cancer Institute.
[52] Melissa L. Finucane,et al. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: A naturally-occurring experiment , 2005, Genetics in Medicine.
[53] L. Feuchtbaum,et al. Tandem mass spectrometry program implementation challenges for state newborn screening programs: national survey of barriers and issues. , 2006, Pediatrics.
[54] M. Khoury,et al. Hemochromatosis-associated morbidity in the United States: An analysis of the National Hospital Discharge Survey, 1979–1997 , 2001, Genetics in Medicine.
[55] C. Mulrow,et al. Current methods of the US Preventive Services Task Force: a review of the process. , 2001, American journal of preventive medicine.
[56] M. Khoury,et al. Expanding the definition of a positive family history for early-onset coronary heart disease , 2006, Genetics in Medicine.
[57] P. Briss,et al. Translating Research into Improved Outcomes in Comprehensive Cancer Control , 2005, Cancer Causes & Control.
[58] Aaron Sloman,et al. The evolution of what , 1998 .
[59] H. Noorani,et al. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry. , 2007, Clinical Biochemistry.
[60] M. Khoury,et al. Human genome epidemiologic reviews: the beginning of something HuGE. , 2000, American journal of epidemiology.
[61] M. Khoury,et al. Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. , 2006, American journal of epidemiology.
[62] J. Westfall,et al. Practice-based research--"Blue Highways" on the NIH roadmap. , 2007, JAMA.
[63] S. Grosse,et al. Newborn screening for inherited metabolic disease , 2007, The Lancet.
[64] Michael B Bracken,et al. Genomic epidemiology of complex disease: the need for an electronic evidence-based approach to research synthesis. , 2005, American journal of epidemiology.
[65] A. Ionescu,et al. When should we suspect osteoporosis in patients with chronic airways disease? , 2005, Chronic respiratory disease.
[66] C. Duijn,et al. Towards predictive genetic testing of complex diseases , 2006, European Journal of Epidemiology.
[67] J. Stockman. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study , 2008 .
[68] M. Province,et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). , 2001, The American journal of cardiology.
[69] John P A Ioannidis,et al. Translation of highly promising basic science research into clinical applications. , 2003, The American journal of medicine.
[70] R. Hiatt,et al. Cancer outcomes research and the arenas of application. , 2004, Journal of the National Cancer Institute. Monographs.
[71] Stephen B. Johnson,et al. Central challenges facing the national clinical research enterprise. , 2003, JAMA.
[72] M. Donaldson,et al. Cancer outcomes research. , 2004, Journal of the National Cancer Institute. Monographs.
[73] E. Harris,et al. Screening for Hereditary Hemochromatosis: A Systematic Review for the U.S. Preventive Services Task Force , 2006, Annals of Internal Medicine.
[74] Rongwei Fu,et al. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force , 2005, Annals of Internal Medicine.
[75] Stephen B. Johnson,et al. Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise. , 2004, JAMA.